MWNA
BMY icon

Marshall Wace North America’s Bristol-Myers Squibb BMY Stock Holding History

Marshall Wace North America’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$48.9M Buy
826,880
+169,274
+26% +$11.1M 0.21% 100
2021
Q2 		$43.9M Sell
657,606
-2,439,729
-79% -$159M 0.18% 121
2021
Q1 		$196M Sell
3,097,335
-741,084
-19% -$46.1M 0.81% 15
2020
Q4 		$238M Buy
3,838,419
+2,991,635
+353% +$184M 1.07% 11
2020
Q3 		$51.1M Buy
846,784
+833,809
+6,426% +$50.2M 0.33% 69
2020
Q2 		$763K Buy
+12,975
New +$776K 0.01% 831
2020
Q1 		– Sell
-45,494
Closed -$2.92M – 1242
2019
Q4 		$2.92M Sell
45,494
-86,932
-66% -$4.98M 0.01% 492
2019
Q3 		$6.71M Sell
132,426
-5,804
-4% -$273K 0.04% 314
2019
Q2 		$6.27M Sell
138,230
-423,615
-75% -$19.7M 0.04% 315
2019
Q1 		$26.8M Buy
561,845
+116,315
+26% +$5.79M 0.19% 116
2018
Q4 		$23.2M Buy
445,530
+258,957
+139% +$13.9M 0.22% 92
2018
Q3 		$11.6M Sell
186,573
-1,294,757
-87% -$76.8M 0.08% 196
2018
Q2 		$82M Buy
1,481,330
+7,476
+0.5% +$404K 0.46% 48
2018
Q1 		$93.2M Buy
1,473,854
+1,252,722
+567% +$80.6M 0.47% 48
2017
Q4 		$13.6M Sell
221,132
-861,196
-80% -$53.9M 0.07% 311
2017
Q3 		$69.3M Buy
1,082,328
+851,692
+369% +$49.7M 0.44% 39
2017
Q2 		$12.9M Buy
230,636
+95,927
+71% +$5.22M 0.09% 262
2017
Q1 		$7.27M Buy
+134,709
New +$7.39M 0.06% 321
2013
Q4 		$268K Buy
+5,039
New +$257K 0.01% 615

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Marshall Wace North America's BMY Position: Q3 2021 in Review

Marshall Wace North America increased its Bristol-Myers Squibb (BMY) stake by 26% in Q3 2021, buying an estimated $11.1M and bringing the position to 826,880 shares worth $48.9M. The position accounts for 0.21% of the portfolio, ranked #100.

Marshall Wace North America first reported a position in BMY in Q4 2013 and has held it in 19 quarters since. The position peaked at $238M in Q4 2020. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

  • Marshall Wace North America held 826,880 shares of Bristol-Myers Squibb worth $48.9M as of Q3 2021.
  • Marshall Wace North America bought 169,274 Bristol-Myers Squibb shares in Q3 2021, an estimated $11.1M.
  • Bristol-Myers Squibb made up 0.21% of Marshall Wace North America's portfolio in Q3 2021, its #100 holding.
  • Marshall Wace North America first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 19 quarters since.
  • Marshall Wace North America's Bristol-Myers Squibb position peaked at $238M in Q4 2020.
  • 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.